Literature DB >> 32843369

Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.

Sen Han1,2, Ting Zhang1, Praveen Kusumanchi1, Nazmul Huda1, Yanchao Jiang1, Suthat Liangpunsakul3,4, Zhihong Yang3.   

Abstract

MicroRNA-7 (miR-7) is a small non-coding RNA, which plays critical roles in regulating gene expression of multiple key cellular processes. MiR-7 exhibits a tissue-specific pattern of expression, with abundant levels found in the brain, spleen, and pancreas. Although it is expressed at lower levels in other tissues, including the liver, miR-7 is involved in both the development of organs and biological functions of cells. In this review, we focus on the mechanisms by which miR-7 controls cell growth, proliferation, invasion, metastasis, metabolism, and inflammation. We also summarize the specific roles of miR-7 in liver diseases. MiR-7 is considered as a tumor suppressor miRNA in hepatocellular carcinoma and is involved in the pathogenesis of hepatic steatosis and hepatitis. Future studies to further define miR-7 functions and its mechanism in association with other types of liver diseases should be explored. An improved understanding from these studies will provide us a useful perspective leading to mechanism-based intervention by targeting miR-7 for the treatment of liver diseases. © American Federation for Medical Research 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  liver diseases

Mesh:

Substances:

Year:  2020        PMID: 32843369      PMCID: PMC9303053          DOI: 10.1136/jim-2020-001420

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   3.235


  110 in total

1.  TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.

Authors:  Wenhui Zhao; Yubin Dai; Ting Dai; Tian Xie; Xiaobo Su; Jing Li; Xiang Zhou; Kewei Meng; Xiaohui Zhao
Journal:  Biochem Biophys Res Commun       Date:  2017-10-28       Impact factor: 3.575

2.  MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.

Authors:  Kaiyao Hua; Jiali Jin; Huiwen Zhang; Bingkun Zhao; Chenyang Wu; Hui Xu; Lin Fang
Journal:  Int J Oncol       Date:  2016-08-18       Impact factor: 5.650

Review 3.  Defining the role of TRIP6 in cell physiology and cancer.

Authors:  Semjon Willier; Elke Butt; Günther H S Richter; Stefan Burdach; Thomas G P Grunewald
Journal:  Biol Cell       Date:  2011-12-01       Impact factor: 4.458

4.  Circulating levels of miR-7, miR-152 and miR-192 respond to vitamin D supplementation in adults with prediabetes and correlate with improvements in glycemic control.

Authors:  Yury O Nunez Lopez; Anastassios G Pittas; Richard E Pratley; Attila A Seyhan
Journal:  J Nutr Biochem       Date:  2017-08-26       Impact factor: 6.048

5.  MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas.

Authors:  Mayrin Correa-Medina; Valia Bravo-Egana; Samuel Rosero; Camillo Ricordi; Helena Edlund; Juan Diez; Ricardo L Pastori
Journal:  Gene Expr Patterns       Date:  2008-12-24       Impact factor: 1.224

6.  MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.

Authors:  Yan Zhou; Ming Lu; Ren-Hong Du; Chen Qiao; Chun-Yi Jiang; Ke-Zhong Zhang; Jian-Hua Ding; Gang Hu
Journal:  Mol Neurodegener       Date:  2016-04-16       Impact factor: 14.195

7.  Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells.

Authors:  Yanna Wang; Qiaoling Wang; Jiqing Song
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

Review 8.  Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA.

Authors:  Iain M Dykes; Costanza Emanueli
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-05-19       Impact factor: 7.691

9.  Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.

Authors:  Qidi Zheng; Zhuojia Lin; Jie Xu; Yanan Lu; Qiuyu Meng; Chen Wang; Yuxin Yang; Xiaoru Xin; Xiaonan Li; Hu Pu; Xin Gui; Tianming Li; Wujun Xiong; Dongdong Lu
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

10.  The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells.

Authors:  Huanyu Xu; Sen Guo; Wei Li; Ping Yu
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

View more
  4 in total

Review 1.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

2.  Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling.

Authors:  Manveen K Gupta; Anita Sahu; Yu Sun; Maradumane L Mohan; Avinash Kumar; Ajaykumar Zalavadia; Xi Wang; Elizabeth E Martelli; Kate Stenson; Conner P Witherow; Judy Drazba; Srinivasan Dasarathy; Sathyamangla V Naga Prasad
Journal:  Sci Rep       Date:  2021-11-10       Impact factor: 4.379

3.  Transcriptomic Analysis Reveals the Messenger RNAs Responsible for the Progression of Alcoholic Cirrhosis.

Authors:  Zhihong Yang; Sen Han; Ting Zhang; Praveen Kusumanchi; Nazmul Huda; Kelsey Tyler; Kristina Chandler; Nicholas J Skill; Wanzhu Tu; Mu Shan; Yanchao Jiang; Jessica L Maiers; Kristina Perez; Jing Ma; Suthat Liangpunsakul
Journal:  Hepatol Commun       Date:  2022-02-08

4.  Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis.

Authors:  Zhihong Yang; Ting Zhang; Praveen Kusumanchi; Qing Tang; Zhaoli Sun; Svetlana Radaeva; Brandon Peiffer; Vijay H Shah; Patrick Kamath; Greg J Gores; Arun Sanyal; Naga Chalasani; Yanchao Jiang; Nazmul Huda; Jing Ma; Suthat Liangpunsakul
Journal:  Hepatology       Date:  2021-07-26       Impact factor: 17.425

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.